Advisers to the Food and Drug Administration (FDA) on June 14 recommended the agency grant emergency authorization to Moderna’s COVID-19 vaccine for children aged 6 to 17.
The advisory panel was asked whether they believe the benefits of the vaccine outweigh the risks, and unanimously voted yes following an eight-hour virtual meeting.
The FDA is not mandated to accept the panel’s recommendations, but typically does.
The only COVID-19 vaccine currently available to youth is Pfizer’s jab…